Biltricidea 600 mg FC tablets
PDF Leaflet Revision Date: 09 December 2021
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of Schistosomiasis caused by S. haematobium and S. mansoni.
Dosage (summary)
40 mg/kg once or 20 mg/kg twice on a single day.
Special Populations
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Not recommended in the first trimester; breastfeeding should be paused during treatment.
Key Drug Interactions
- Cimetidine
- Ketoconazole
- Rifampicin
Contraindications
- Hypersensitivity to praziquantel
- Ocular cysticercosis
Common side effects
- Headache
- Dizziness
- Nausea
- Fatigue
Counselling Points
- Take with liquid during or after meals
- Avoid driving or operating machinery on treatment day
Serious warnings
- Caution in liver insufficiency
- Potential for life-threatening reactions in acute schistosomiasis
Important Disclaimer
The Biltricidea 600 mg FC tablets professional information leaflet below is the property of Bayer and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
